Journal article
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
-
Notturno F
Department of Neuroscience and Imaging, University "G. d'Annunzio", Chieti-Pescara, Italy. Electronic address: francnotturno@yahoo.it.
-
Di Febo T
Experimental Zooprophylactic Institute of Abruzzo and Molise "G. Caporale", Teramo, Italy.
-
Yuki N
Department of Medicine, National University of Singapore, Singapore; Department of Physiology, National University of Singapore, Singapore.
-
Fernandez Rodriguez BM
Institute for Research in Biomedicine, Bellinzona, Switzerland.
-
Corti D
Institute for Research in Biomedicine, Bellinzona, Switzerland.
-
Nobile-Orazio E
2nd Neurology, Department of Medical Biotechnology and Translational Medicine, IRCCS Humanitas Clinical Institute, Milan University, Rozzano, Milan, Italy.
-
Carpo M
Neurology Unit, Ospedale Treviglio, Bergamo, Italy.
-
De Lauretis A
Department of Respiratory Medicine, Catholic University, Rome, Italy.
-
Uncini A
Department of Neuroscience and Imaging, University "G. d'Annunzio", Chieti-Pescara, Italy.
Show more…
Published in:
- Journal of neuroimmunology. - 2014
English
We tested autoantibodies to neurofascin-186 (NF186) and gliomedin in sera from patients with multifocal motor neuropathy (MMN, n=53) and chronic inflammatory demyelinating polyneuropathy (CIDP, n=95) by ELISA. IgG antibodies to NF186 or gliomedin were found in 62% of MMN and 1% of CIDP sera, and IgM antibodies to the same antigens in 12% of MMN and 1% of CIDP sera. These autoantibodies activated complement. Ten percent of the MMN sera without IgM anti-GM1 reactivity had anti-NF186 antibodies. Because NF186 and gliomedin play a crucial role for salutatory conduction, the autoantibodies may contribute to produce motor nerve conduction block and muscle weakness in MMN.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/210209
Statistics
Document views: 15
File downloads: